The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 2,953 | 39,000 | SH | SOLE | 39,000 | 0 | 0 | ||
| AC IMMUNE SA | SHS | H00263105 | 6,180 | 1,248,453 | SH | SOLE | 1,248,453 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 2,440 | 548,409 | SH | SOLE | 548,409 | 0 | 0 | ||
| ALBIREO PHARMA INC | COM | 01345P106 | 5,050 | 252,500 | SH | SOLE | 252,500 | 0 | 0 | ||
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 4,165 | 790,228 | SH | SOLE | 790,228 | 0 | 0 | ||
| ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 7,467 | 163,133 | SH | SOLE | 163,133 | 0 | 0 | ||
| ARQULE INC | COM | 04269E107 | 2,616 | 364,797 | SH | SOLE | 364,797 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 6,063 | 89,952 | SH | SOLE | 89,952 | 0 | 0 | ||
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 15,461 | 304,900 | SH | SOLE | 304,900 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 2,741 | 558,159 | SH | SOLE | 558,159 | 0 | 0 | ||
| CIGNA CORP | COM | 125523100 | 1,670 | 11,000 | SH | SOLE | 11,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 2,309 | 587,626 | SH | SOLE | 587,626 | 0 | 0 | ||
| CENTENE CORP | COM | 15135B101 | 7,138 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
| HOMOLOGY MEDICINES INC | COM | 438083107 | 2,775 | 153,303 | SH | SOLE | 153,303 | 0 | 0 | ||
| GUARDANT HEALTH INC | COM | 40131M109 | 2,662 | 41,700 | SH | SOLE | 41,700 | 0 | 0 | ||
| HANGER INC | COM NEW | 41043F208 | 8,050 | 395,000 | SH | SOLE | 395,000 | 0 | 0 | ||
| HUMANA INC | COM | 444859102 | 3,068 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 6,300 | 346,149 | SH | SOLE | 346,149 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 13,473 | 888,152 | SH | SOLE | 888,152 | 0 | 0 | ||
| MEIRAGTX HOLDINGS PLC | COM | G59665102 | 5,393 | 338,096 | SH | SOLE | 338,096 | 0 | 0 | ||
| MILLENDO THERAPEUTICS INC | COM | 60040X103 | 370 | 52,051 | SH | SOLE | 52,051 | 0 | 0 | ||
| MOLECULAR TEMPLATES INC | COM | 608550109 | 1,470 | 222,994 | SH | SOLE | 222,994 | 0 | 0 | ||
| PERSONALIS INC | COM | 71535D106 | 1,691 | 115,214 | SH | SOLE | 115,214 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 12,949 | 328,978 | SH | SOLE | 328,978 | 0 | 0 | ||
| R1 RCM INC | COM | 749397105 | 3,652 | 408,958 | SH | SOLE | 408,958 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC-A | CL A | 75615P103 | 5,025 | 62,591 | SH | SOLE | 62,591 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 6,011 | 2,515,072 | SH | SOLE | 2,515,072 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM | 82640U107 | 924 | 2,366,707 | SH | SOLE | 2,366,707 | 0 | 0 | ||
| TELIGENT INC | COM | 87960W104 | 2,323 | 2,446,043 | SH | SOLE | 2,446,043 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 7,754 | 325,385 | SH | SOLE | 325,385 | 0 | 0 | ||
| UROVANT SCIENCES LTD | SHS | G9381B108 | 972 | 102,657 | SH | SOLE | 102,657 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP | COM | 91307C102 | 10,602 | 132,937 | SH | SOLE | 132,937 | 0 | 0 | ||
| ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | 17,571 | 128,000 | SH | SOLE | 128,000 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CALL | 75615P903 | 988 | 12,300 | SH | Call | SOLE | 12,300 | 0 | 0 | |